Responses in vaccinees included Ad48 neutralizing antibody ( nAb ) titers higher than Ad5 nAb titers , EnvA-specific enzyme-linked immunosorbent assay titers , and EnvA-specific enzyme-linked immunospot assay responses , and these responses generally persisted at week 52 .